硫酸镁单药及联合拉贝洛尔对子痫前期患者血液流变学指标的影响观察

Effects of magnesium sulfate monotherapy and its combination with labetalol on hemorheological parameters in patients with pregnancy-induced hypertension

  • 摘要: 目的 探讨硫酸镁单药及联合拉贝洛尔对子痫前期患者血流动力学、血液流变学、妊娠结局的影响。 方法 选取126例子痫前期患者,按随机数字表法分为观察组与对照组,各63例,对照组采用硫酸镁单药治疗,观察组采用硫酸镁联合拉贝洛尔治疗,比较2组治疗前后血流动力学、子宫动脉血流参数[动脉搏动指数(PI)、动脉收缩压与舒张末期峰值血流速度比值(S/D)、动脉血流阻力指数(RI)]、血液流变学指标(全血还原黏度、血浆黏度、红细胞压积、纤维蛋白原)、抗氧化能力[丙二醛(MDA)、谷胱甘肽过氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)]变化,观察2组用药不良反应及不良妊娠结局发生情况。 结果 治疗后,观察组24 h平均收缩压、24 h平均舒张压、24 h平均动脉压、PI、S/D、RI、全血还原黏度、血浆黏度、红细胞压积、纤维蛋白原均低于对照组,差异有统计学意义(P<0.05); 观察组MDA低于对照组, GSH-Px、SOD高于对照组,差异有统计学意义(P<0.05); 2组用药不良反应总发生率比较,差异无统计学意义(P>0.05); 观察组不良妊娠结局总发生率33.33%, 低于对照组60.32%, 差异有统计学意义(P<0.05)。 结论 硫酸镁联合拉贝洛尔用于子痫前期的治疗,能有效改善患者血压及子宫动脉血流,降低血液黏度,提高抗氧化能力,减少不良妊娠结局。

     

    Abstract: Objective To observe the effects of magnesium sulfate monotherapy and its combination with labetalol on hemodynamics, hemorheology and pregnancy outcomes in patients with pregnancy-induced hypertension. Methods A totalof 126 patients with pregnancy-induced hypertension were divided into observation group and control group according to the random number table method, with 63 cases in each group. Control group was given monotherapy of magnesium sulfate, and observation group was given magnesium sulfate and its combination with labetalol. The hemodynamics, uterine artery blood flow parameters [arterial pulsatility index(PI), ratio of arterial systolic pressure to end-diastolic peak blood flow velocity(S/D), arterial blood flow resistance index(RI)], hemorheology(whole blood reduction viscosity, plasma viscosity, hematocrit, fibrinogen)and antioxidant capacity [malondialdehyde(MDA), glutathione peroxidase(GSH-Px), superoxide dismutase(SOD)] before and after treatment were compared between thetwo groups, and the occurrence of adverse drug reactions and adverse pregnancy outcomes were observed in the two groups. Results After treatment, the 24 h mean systolic blood pressure, 24 h mean diastolic blood pressure, 24 h mean arterial pressure, PI, S/D, RI, whole blood reduction viscosity, plasma viscosity, hematocrit and fibrinogen in observation group were significantly lower than those in control group(P<0.05). The MDA - in observation group was significantly lower than that in control group(P<0.05), while the GSH-Px and SOD were significantly higher than those in control group(P<0.05). There was no statistically significant difference in the total incidence of adverse drug reactions between the two groups(P>0.05). The total incidence rate of adverse pregnancy outcomes in observation group was significantly lower than that in control group(33.33%vs. 60.32%, P<0.05). Conclusion Magnesium sulfate combined with labetalol for treatment of pregnancy-induced hypertension can effectively improve blood pressure and uterine artery blood flow, reduce blood viscosity and improve antioxidant capacity, and reduce adverse pregnancy outcomes.

     

/

返回文章
返回